z-logo
Premium
Relationship between response to inhaled salbutamol and methacholine bronchial provocation in children with suspected asthma
Author(s) -
Bibi Haim,
Montgomery Mark,
Pasterkamp Hans,
Chernick Victor
Publication year - 1991
Publication title -
pediatric pulmonology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.866
H-Index - 106
eISSN - 1099-0496
pISSN - 8755-6863
DOI - 10.1002/ppul.1950100404
Subject(s) - salbutamol , medicine , asthma , methacholine , provocation test , asymptomatic , anesthesia , gastroenterology , respiratory disease , pathology , lung , alternative medicine
Fifty children (27 females, 23 males) ages 6–15 years who were referred for evaluation of suspected asthma had baseline FEV 1 and FEF 25‐75 of ⩾ 80% and FEF 50 ⩾ 70% of predicted values. All had these tests repeated on the same day, after inhaling salbutamol. On a subsequent day PC‐20 (methacholine) was determined as an index of bronchial hyperreactivity (BH). Fourteen age‐matched healthy children (6 females, 8 males) were studied in a similar manner. There was no significant relationship between the PC 20 and the change in FEF 25‐75 or FEF 50 following salbutamol. There was a negative correlation between the initial FEV 1 (% predicted) and the percent change in FEV 1 following salbutamol ( P < 0.01). An increase in FEV 1 of >6% occurred in 7/12 (58.3%) patients with PC 20 ⩽ 0.25 mg/mL (Group I); in 7/24 (29.2%) patients with PC 20 = 0.26–2.0 mg/mL (Group II); in only 1/14 (7.1%) patients with PC 20 > 2.1 mg/mL (Group III) and in none of those asymptomatic (control) children with PC 20 > 8.0 mg/mL (Group IV). All subjects who had a change in FEV 1 > 6% after salbutamol had a PC 20 < 8 mg/mL and this test detected the majority of patients with severe BH. However, although the sensitivity of the test was 100%, the predictive value was only 36%. We conclude that in the presence of a normal baseline FEV 1 a change of > 6% following salbutamol inhalation is indicative of bronchial hyperreactivity. Pediatr Pulmonol 1991; 10:244–248.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom